Based on the expression of human epidermal growth factor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR), and Ki67, physicians classified breast cancer as luminal A, luminal B, Her2-enriched, and triple-negative subtype [2]. Here, ERBB2 is linked to breast cancer.